The University of Southampton
University of Southampton Institutional Repository

Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study

Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
Objectives Osteolysis and subsequent prosthesis loosening is the most common cause for revision following total knee arthroplasty (TKA) or total hip arthroplasty (THA). Hormone replacement therapy (HRT) could reduce osteolysis through its antiresorptive effects. We studied whether HRT use is associated with reduced revision rates in a community-based cohort of women undergoing TKA or THA for osteoarthritis.

Methods Female participants in the General Practice Research Database undergoing a primary TKA or THA from 1986 to 2006 were included. We excluded patients aged <40 years at the date of primary, and those with a history of previous hip fracture or rheumatoid arthritis. Women with at least 6 months of HRT were identified as HRT users. We further explored the associations among HRT use of ≥12 months, adherence (medication possession ratio) and cumulative use and revision risk. Cox models were fitted to model implant survival in years. Propensity score matching was used to control for confounding.

Results We matched 2700 HRT users to 8100 non-users, observed for a median (IQR) of 3.3 (1.5–6.1) years after TKA/THA. HR for HRT ≥6 months was 0.62 (95% CI 0.41 to 0.94), whereas HR for ≥12 months was 0.48 (0.29 to 0.78). Higher adherence and therapy duration were associated with further reductions in revision rates. Preoperative HRT appeared unrelated to implant survival.

Conclusions HRT use is associated with an almost 40% reduction in revision rates after a TKA/THA. These findings require replication in external cohorts and experimental studies.

0003-4967
557-563
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Maskell, J.
20c51b6e-66ca-4d3f-a463-ba5a3168aeb8
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Maskell, J.
20c51b6e-66ca-4d3f-a463-ba5a3168aeb8
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f

Prieto-Alhambra, D., Javaid, M.K., Judge, A., Maskell, J., Cooper, C. and Arden, N.K. (2015) Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Annals of the Rheumatic Diseases, 74 (3), 557-563. (doi:10.1136/annrheumdis-2013-204043). (PMID:24451241)

Record type: Article

Abstract

Objectives Osteolysis and subsequent prosthesis loosening is the most common cause for revision following total knee arthroplasty (TKA) or total hip arthroplasty (THA). Hormone replacement therapy (HRT) could reduce osteolysis through its antiresorptive effects. We studied whether HRT use is associated with reduced revision rates in a community-based cohort of women undergoing TKA or THA for osteoarthritis.

Methods Female participants in the General Practice Research Database undergoing a primary TKA or THA from 1986 to 2006 were included. We excluded patients aged <40 years at the date of primary, and those with a history of previous hip fracture or rheumatoid arthritis. Women with at least 6 months of HRT were identified as HRT users. We further explored the associations among HRT use of ≥12 months, adherence (medication possession ratio) and cumulative use and revision risk. Cox models were fitted to model implant survival in years. Propensity score matching was used to control for confounding.

Results We matched 2700 HRT users to 8100 non-users, observed for a median (IQR) of 3.3 (1.5–6.1) years after TKA/THA. HR for HRT ≥6 months was 0.62 (95% CI 0.41 to 0.94), whereas HR for ≥12 months was 0.48 (0.29 to 0.78). Higher adherence and therapy duration were associated with further reductions in revision rates. Preoperative HRT appeared unrelated to implant survival.

Conclusions HRT use is associated with an almost 40% reduction in revision rates after a TKA/THA. These findings require replication in external cohorts and experimental studies.

This record has no associated files available for download.

More information

Accepted/In Press date: 24 November 2013
e-pub ahead of print date: 22 January 2014
Published date: 5 February 2015
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 375458
URI: http://eprints.soton.ac.uk/id/eprint/375458
ISSN: 0003-4967
PURE UUID: d05e0209-ee61-4955-8e42-14714d28838d
ORCID for C. Cooper: ORCID iD orcid.org/0000-0003-3510-0709

Catalogue record

Date deposited: 27 Mar 2015 11:22
Last modified: 18 Mar 2024 02:45

Export record

Altmetrics

Contributors

Author: D. Prieto-Alhambra
Author: M.K. Javaid
Author: A. Judge
Author: J. Maskell
Author: C. Cooper ORCID iD
Author: N.K. Arden

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×